Latest Fractyl Health News & Updates

See the latest news and media coverage for Fractyl. We track all announcements, press releases, and industry mentions in real time, all in one place.

Fractyl Health (Fractyl)

Developer of metabolic therapies for obesity and type 2 diabetes

fractyl.com

Headquarters: Burlington, United States
Founded year: 2010
Company type: Public company
Number of employees: 100–200
Industry: Biotechnology & Medical Research

Last updated October 22

Latest news about Fractyl Health (Fractyl)

In short: Fractyl reported positive Revita trial results, cut 45% of staff and halted Rejuva development

Company announcements

October 22 Fractyl

Fractyl Health focuses on Revita and reduces staff after positive trial results

The company lays off 45% of its workforce, halts Rejuva development, and extends its cash runway into Q2 2027 while preparing an FDA submission for Revita.

October 16 Fractyl

Fractyl Health Revita meets primary endpoint in REMAIN-1 study

Revita demonstrated statistically significant weight maintenance after GLP-1 discontinuation. Fractyl plans FDA De Novo submission late Q4 2026 for this procedural therapy.

August 10 Fractyl

Fractyl reports durable weight maintenance after GLP-1 discontinuation

Data show optimized patients maintained 84% of prior GLP-1-induced weight loss vs 46% for sham, with no serious device-related events; REVEAL-1 corroborates results.

August 3 Fractyl

Fractyl reported Q2 2026 financial results and business updates

One-year REMAIN-1 data show durable weight maintenance after Revita, with pivotal readout expected early Q4 2026 and cash runway into early 2027.

Media coverage

October 22 MedCity News

Fractyl's Weight Maintenance Device Meets Clinical Goal, but Shares Nosedive, Layoffs Follow

Fractyl Health reported positive six-month trial results from an investigation of its Revita procedure last week, but shares of Fractyl stock dropped steeply on October...

October 16 BioWorld

Fractyl bets it all on Revita therapy to maintain weight loss

Fractyl Health Inc. is determined to pursue the development of its Revita system despite its battered share price and looming litigation. It is cutting nearly...

October 3 AInvest

The Readout, Not the Solicitation, Is What Cost Fractyl Health (GUTS) Three-Quarters of Its Value

Fractyl Health GUTS-- (GUTS) lost 74.86% of its value after weak Revita trial data revealed 4.5% weight regain vs. 7.5% in ...

October 1 TipRanks

Fractyl Health Implements One-for-Twelve Reverse Stock Split - TipRanks.com

The latest update is out from Fractyl Health, Inc. ( ($GUTS) ). On September 30, 2026, Fractyl Health, Inc. filed an amendment to its charter...

Never miss news about Fractyl

Track Fractyl and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Fractyl competitors & trending companies

Browse news for competitors to Fractyl and other trending companies.